Lung Cancer Study Leads to New Screening Program

Lung Cancer Screening
Print icon

Need to know more about lung cancer? Click here to download your free guide.  

Following national research data demonstrating substantial improvements in lung cancer mortality, Hartford HealthCare  researchers completed their own study exploring the feasibility of lung cancer screening in Connecticut.

In a landmark study sponsored by the National Cancer Institute, researchers with the National Lung Screening Trial screened more than 53,000 current or former heavy smokers and concluded that participants undergoing  low-dose helical computed tomography (CT) scans were 15 to 20 percent less likely to die from lung cancer than those being screened by standard chest X-rays. A CT scan provides an image of the entire chest, allowing doctors to identify nodules that might be a sign of cancer.

A team from the Hartford HealthCare Cancer Institute, led by principal investigator Dr. Andrew Salner, used the national findings as the foundation for its Lung Cancer Screening Study. The team – which included Drs. Thomas Farquhar and John Volpe from Hartford Hospital, Dr. Eric Gorny from The Hospital of Central Connecticut, Dr. James Carroll from MidState Medical Center and Dr. Robert Bundy from Windham Hospital – visited Lahey Clinic, an early adopter and research center for lung cancer screening. The goal was to draw on best practices and create a screening study that could be offered to eligible patients at all Hartford HealthCare hospitals.

Need to know more about lung cancer? Click here to download your free guide.  

From 2014 to 2016, almost 1,000 people were enrolled in the Lung Cancer Screening Study and underwent annual CT screenings. Active smokers were also counseled for smoking cessation. Of the study participants:

  • 6 percent had suspicious findings.
  • 124 were found to have unrelated abnormalities, most of which were benign, of other tissues such as the thyroid, breast, aorta, heart, mediastinum, kidney, rib and chest wall or liver.
  • 16 had a new primary lung malignancy; 75 percent of these had stage 1 disease.

“An essential philosophy of cancer investigation is to recognize that, in order to learn something, we must ask the right question,” said Dr. Salner, who is also medical director of the Cancer Institute at Hartford Hospital. “In order to answer it, we must design the right research strategy.

“Our research project not only allowed us to gain needed experience with this new modality, but also helped us implement a new program under the rigor of a research project, with a primary care referral orientation and the ability to reach all the communities we serve.”

As a result, primary care physicians in the community can refer patients to the Cancer Institute Lung Cancer Screening Program at the closest Hartford HealthCare acute care hospital. Routinely covered by most insurance plans, the screening takes about 10 minutes and is painless.

“Most importantly, we know that this can save lives,” Dr. Salner said.

Need to know more about lung cancer? Click here to download your free guide.  

 


What's New

Truncal Lymphedema

When Breast Cancer Treatments Cause Truncal Lymphedema

Lymphedema, a collection of fluid that can cause swelling, is possible anywhere in the body but seems to be identified and addressed more commonly when it happens in an arm or leg. When persistent swelling occurs in the underarm, breast, or chest, patients will often decide to wait and see...

Breast Cancer Surgery

New: Radiofrequency Seeds Aid Breast Surgery, Improve Cosmetic Results

Not all breast disease can be felt, so surgeons have developed ways to mark the lump or lesion for more effective removal. At Hartford HealthCare, that process just got a lot more high-tech and efficient. This month, the Hartford HealthCare Cancer Institute Breast Program becomes the first in the state...

PSA test

How to Stop Prostate Cancer? It Starts With a PSA Test

Dr. Ryan Dorin, a urologist at the Hartford HealthCare Tallwood Urology & Kidney Institute, says the PSA test remains the best way to detect prostate cancer at its earliest stages and give the patient the best chance at successful treatment. Here’s a quick Q&A: Q: There has been a fair...


Rethinking Immunity to Help Beat Cancer

By Dr. Peter Yu Physician-in-Chief, Hartford HealthCare Cancer Institute It is frightening to receive a cancer diagnosis. But there is more hope than ever before. Through clinical trials and research, we are developing new treatments that help people live longer and better lives – and actually cure an increasing number of...

Cancer Recovery and Physical Activiity

The Importance of Physical Activity in Cancer Survivorship

By Gretchin Bade Program Director of Oncology Hartford Hospital Rehabilitation Network At least 20 studies of people with breast, colorectal, prostate and ovarian cancer have suggested that physically active cancer survivors have a lower risk of cancer recurrence and improved survival compared to survivors who are inactive. Exercise also has...

Colorectal Cancer

Rebuilding Your Life After Colorectal Cancer Diagnosis

Dr. Gerard Fumo Physician Lead, Hartford HealthCare Gastrointestinal Disease Management Team Colorectal cancer, a potentially lethal disease, is one of the most preventable cancers because doctors can remove precancerous growths during a colonoscopy. In part, because of the advances in screening, which leads to detection and removal of early cancers,...